Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
310 USD | +0.18% | -1.07% | +8.10% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.10% | 166B | |
+39.85% | 723B | |
+34.28% | 595B | |
-3.97% | 369B | |
+20.47% | 332B | |
+2.99% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
-0.02% | 168B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating